UPDATE 1-U.S. appeals court declines J&J bid to stop generic Zytiga sales
November 21, 2018 at 15:10 PM EST
A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of its blockbuster prostate cancer drug Zytiga from hitting the U.S. market.
